Sandbox:iqra: Difference between revisions
Jump to navigation
Jump to search
Line 19: | Line 19: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fatigue | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fatigue | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | ||
Line 39: | Line 39: | ||
|- | |- | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congestive | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congestive | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Cirrhosis | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Cirrhosis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 66: | Line 66: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Heart failure | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Congestive heart failure|Heart failure]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 345: | Line 345: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fatigue | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fatigue | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | ||
Line 648: | Line 648: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fatigue | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fatigue | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | ||
Line 921: | Line 921: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fatigue | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fatigue | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP |
Revision as of 22:34, 25 September 2018
Splenomegaly differential:
Category | Disease | Etiology | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | Lab Findings | Imaging | ||||||||||||||||||||||
Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | CBC | PS | Iron | LFT | PT/PTT | BUN/Cr | UA | |||||||||||
WBC | Hb | Plt | |||||||||||||||||||||||||
Congestive | Cirrhosis | ||||||||||||||||||||||||||
Heart failure | |||||||||||||||||||||||||||
Thrombosis of portal, hepatic, or splenic veins | |||||||||||||||||||||||||||
Malignancy | Lymphoma | ||||||||||||||||||||||||||
Leukemias | |||||||||||||||||||||||||||
Polycythemia Vera | |||||||||||||||||||||||||||
Multiple myeloma | |||||||||||||||||||||||||||
Essential thrombocythemia | |||||||||||||||||||||||||||
Primary myelofibrosis | |||||||||||||||||||||||||||
Primary splenic tumors | |||||||||||||||||||||||||||
Metastatic solid tumors | |||||||||||||||||||||||||||
Category | Disease | Etiology | Demography | History | Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | PS | Iron | LFT | PT/PTT | BUN/Cr | UA | Imaging | Gold standard | Associated findings | |
Infection | Viral | Hepatitis, infectious mononucleosis, cytomegalovirus | |||||||||||||||||||||||||
Bacterial | Salmonella, Brucella, tuberculosis | ||||||||||||||||||||||||||
Parasitic | Malaria, schistosomiasis, toxoplasmosis | ||||||||||||||||||||||||||
Kala-azar (visceral leishmaniasis) | |||||||||||||||||||||||||||
Infective endocarditis | |||||||||||||||||||||||||||
Fungal | |||||||||||||||||||||||||||
Inflammation | Sarcoid | ||||||||||||||||||||||||||
Serum sickness | |||||||||||||||||||||||||||
Systemic lupus erythematosus | |||||||||||||||||||||||||||
Felty syndrome | |||||||||||||||||||||||||||
Category | Disease | Etiology | Demography | History | Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | PS | Iron | LFT | PT/PTT | BUN/Cr | UA | Imaging | Gold standard | Associated findings | |
Infiltrative | Gaucher disease | ||||||||||||||||||||||||||
Niemann-Pick disease | |||||||||||||||||||||||||||
Amyloidosis | |||||||||||||||||||||||||||
Langerhans cell histiocytosis | |||||||||||||||||||||||||||
Hemophagocytic lymphohistiocytosis | |||||||||||||||||||||||||||
Rosai-Dorfman disease | |||||||||||||||||||||||||||
Hematologic (hypersplenic) states | Hemolytic anemia | ||||||||||||||||||||||||||
Sickle cell disease | |||||||||||||||||||||||||||
Granulocyte colony-stimulating factor | |||||||||||||||||||||||||||
Category | Disease | Etiology | Demography | History | Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | PS | Iron | LFT | PT/PTT | BUN/Cr | UA | Imaging | Gold standard | Associated findings |